Showing results (111-120 of 131) with videos related to
Sort By:
Pageof 14
Oncogene|May 16, 2018
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitorsKatrien Berns, Joseph J Caumanns, E Marielle Hijmans, et al.International Journal of Radiation Oncology, Biology, Physics|August 22, 2009
The prognostic value of TRAIL and its death receptors in cervical cancerJohn H Maduro, Maartje G Noordhuis, Klaske A ten Hoor, et al.Journal of Psychiatric Research|May 10, 2014
Deficits in metacognitive capacity distinguish patients with schizophrenia from those with prolonged medical adversityPaul H Lysaker, Jenifer Vohs, Jay A Hamm, et al.NAR Cancer|November 29, 2024
RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft modelsFrancien Talens, Vivian Oliviera Nunes Teixeira, Yannick P Kok, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft modelEvelien W Duiker, Elisabeth G E de Vries, Devalingam Mahalingam, et al.Theranostics|May 7, 2026
Elevated target expression by dual PD-L1 and 4-1BB engagement is associated with 89Zr-PD-L1x4-1BB bispecific Mabcalin tumor uptakeClaudia A J van Winkel, Xiaoyu Fan, Danique Giesen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2012
Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft modelArne R M van der Bilt, Anton G T Terwisscha van Scheltinga, Hetty Timmer-Bosscha, et al.Circulation|February 21, 2018
Heart Failure Stimulates Tumor Growth by Circulating FactorsWouter C Meijers, Manuel Maglione, Stephan J L Bakker, et al.International Journal of Cancer|February 11, 2012
The role of ATM and 53BP1 as predictive markers in cervical cancerFrank Roossink, Hylke W Wieringa, Maartje G Noordhuis, et al.Plos One|July 9, 2020
Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 geneLorenza Mittempergher, Anna M Piskorz, Astrid J Bosma, et al.Pageof 14